Tech Deals Gear Up – 9 New Stocks to Watch This Week

Advertisement

Last week, the market for new stocks kept up its winning ways. There were IPOs stocks hitting the market, raising a total of $5.8 billion. And yes, some of the new stocks had solid gains, with CyberArk Software (CYBR) up 86% and CONE Midstream Partners LP (CNNX) posting a return of 34%.

As for this week, the pipeline is again robust. However, there could be some difficulties since the overall equities markets have been experiencing volatility.

So let’s take a look at each of the new stock slated to go public this week:

New Stocks to Watch: American Addiction Centers (AAC)

Expected Offering Date: Thursday

American Addiction Centers operates six facilities for inpatient substance abuse treatment services (in Nevada, Texas, California and Florida). There are also three more locations under development. Yet acquisitions have been a key part of the growth strategy.

During the first half of this year, revenues experienced zero growth, stuck at $59 million, and adjusted EBITDA dropped by 18% to $8 million. About 90% of revenues were reimbursable by commercial payors, and there was nothing from Medicare and Medicaid.

American Addiction Centers plans to issue 5.8 million shares at a price range of $12 to $14. The lead underwriters include William Blair and Raymond James.

New Stocks to Watch: Atento (ATTO)

Expected Offering Date: Thursday

Founded as a part of Telefonica Group, Atento has turned into the dominant CRM (customer relationship management) software provider in Latin America and Spain. The company also offers services, such as with outsourced call centers.

However, growth has been meager. For the first six months of this year, revenues dropped by 1% to $1.2 billion. But at the same time, the company was able to grow its adjusted EBITDA by 6% to $132 million.

Atento expects to issue 20.1 million shares at a price range of $19 to $22. The lead underwriters include Morgan Stanley (MS), Credit Suisse (CS) and Itau BBA.

New Stocks to Watch: Calithera Biosciences (CALA)

Expected Offering Date: Thursday

Calithera Biosciences is a clinical-stage biotech company that is focused on small molecule drugs, which are targeted for the treatment of cancer. At the core of the science is tumor metabolism and tumor immunology.

The lead candidate is CB-839, which is for the treatment of solid and hematological tumors. The drug is currently in Phase 1 clinical trials.

Calithera Biosciences plans to issue 6 million shares at a price range of $13 to $15. The lead underwriters include Citi (C) and Leerink Partners.

New Stocks to Watch: JP Energy Partners LP (JPEP)

Expected Offering Date: Thursday

JP Energy Partners is a limited partnership, formed by ArcLight Capital, that is focused on developing and operating midstream energy assets. There are four main segments, which include crude oil pipelines and storage, crude oil supply and logistics, refined products terminals and storage and NGL distribution and sales. The assets are located in the Permian Basin, Mid-Continent and Eagle Ford shale.

Despite this diversity, the business has been volatile. For the first half of 2014, revenues fell by 12% to $866 million and adjusted EBITDA plunged by more than 50% to $12 million.

JP Energy Partners expects to issue 15.8 million shares at a price range of $19 to $21. The lead underwriters include Barclays (BCS), Bank of America Merrill Lynch (BAC), Deutsche Bank (DB) and RBC Capital Markets.

New Stocks to Watch: Vivint Solar (VSLR)

Expected Offering Date: Thursday

Vivint Solar sells solar energy systems to residential customers based on 20-year contracts. Generally, the prices are lower than utility rates.

So far, the company has about a 9% market share in the U.S., making it the No. 2 player behind SolarCity (SCTY). And yes, growth has been staggering. For the first six months of this year, revenues have surged more than 500% to $10 million … but the company still posted a loss of $64 million. Vivint has about 850,000 subscribers.

Vivint Solar expects to issue 20.6 million shares at a range of $16 to $18. The lead underwriters include Goldman Sachs (GS), Bank of America Merrill Lynch, Credit Suisse, Citi, Deutsche Bank, Morgan Stanley, Barclays and Blackstone Capital Markets (BX).

New Stocks to Watch: VWR (VWR)

Expected Offering Date: Thursday

Founded more than 160 years ago, VWR is one of the world’s largest providers of lab equipment and services, maintaining relationships with more than 4,000 suppliers. The company also provides custom manufacturing for its customers as well as private-label offerings.

For the first six months of 2014, the company generated net sales of $2.16 billion and adjusted EBITDA of $217 million.

VWR expects to issue 25.5 million shares at a range of $22 to $25. The lead underwriters include Bank of America Merrill Lynch, Goldman Sachs, J.P. Morgan (JPM), Barclays, Deutsche Bank, Citi, Jefferies and William Blair.

New Stocks to Watch: Wayfair (W)

Expected Offering Date: Thursday

Wayfair is an ecommerce site for home products, such as furniture, home furnishings and décor. The company’s typical customer is between ages 35 to 65, female and has annual income of $60,000 to $175,000.

For the first half of this year, revenues came to $915.8 million — up 49.8% on a year-over-year basis — and the average order came to roughly $211. But the company posted a net loss of $15.5 million for the current year.

Wayfair expects to issue 12.6 million shares at a price of $25 to $28. The lead underwriters include Goldman Sachs, Bank of America Merrill Lynch and Citi

New Stocks to Watch: Dermira (DERM)

Expected Offering Date: Friday

Dermira is a biopharma company that is focused on developing treatments for treating acne and other dermatological ailments. The company has five products in the pipeline, with three in the late stages of approval, such as Cimzia (for moderate-to-severe plaque psoriasis), DRM04 (for hyperhidrosis or excessive sweating) and DRM01 (for acne).

Dermira plans to issue 6.2 million shares at a range of $14 to $16. The lead underwriters include Citi and Leerink Partners.

New Stocks to Watch: Yodlee (YDLE)

Expected Offering Date: Friday

Yodlee is a software firm that develops applications and provides data sources for financial services companies and websites. The technology helps with reviewing accounts, tracking spending, managing finances, etc.

During the first half of this year, revenues increased by 29% to $41.1 million and Yodlee posted a profit of $900,000. The company sells its applications and data via subscription plans to more than 750 customers.

Yodlee expects to sell 7.2 million shares at a range of $11 to $13. The lead underwriters include Goldman Sachs, Credit Suisse and Bank of America Merrill Lynch.

Tom Taulli runs the InvestorPlace blog IPO Playbook. He is also the author of High-Profit IPO StrategiesAll About Commodities and All About Short Selling. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities.


Article printed from InvestorPlace Media, https://investorplace.com/ipm_ipo_pb/new-stocks-to-watch-vivant-solar/.

©2024 InvestorPlace Media, LLC